IBDEI3GT ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,58282,1,4,0)
;;=4^E08.319
;;^UTILITY(U,$J,358.3,58282,2)
;;=^5002511
;;^UTILITY(U,$J,358.3,58283,0)
;;=E08.321^^272^2905^35
;;^UTILITY(U,$J,358.3,58283,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58283,1,3,0)
;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,58283,1,4,0)
;;=4^E08.321
;;^UTILITY(U,$J,358.3,58283,2)
;;=^5002512
;;^UTILITY(U,$J,358.3,58284,0)
;;=E08.329^^272^2905^36
;;^UTILITY(U,$J,358.3,58284,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58284,1,3,0)
;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58284,1,4,0)
;;=4^E08.329
;;^UTILITY(U,$J,358.3,58284,2)
;;=^5002513
;;^UTILITY(U,$J,358.3,58285,0)
;;=E08.331^^272^2905^37
;;^UTILITY(U,$J,358.3,58285,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58285,1,3,0)
;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,58285,1,4,0)
;;=4^E08.331
;;^UTILITY(U,$J,358.3,58285,2)
;;=^5002514
;;^UTILITY(U,$J,358.3,58286,0)
;;=E08.339^^272^2905^38
;;^UTILITY(U,$J,358.3,58286,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58286,1,3,0)
;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58286,1,4,0)
;;=4^E08.339
;;^UTILITY(U,$J,358.3,58286,2)
;;=^5002515
;;^UTILITY(U,$J,358.3,58287,0)
;;=E08.341^^272^2905^39
;;^UTILITY(U,$J,358.3,58287,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58287,1,3,0)
;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,58287,1,4,0)
;;=4^E08.341
;;^UTILITY(U,$J,358.3,58287,2)
;;=^5002516
;;^UTILITY(U,$J,358.3,58288,0)
;;=E08.349^^272^2905^40
;;^UTILITY(U,$J,358.3,58288,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58288,1,3,0)
;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58288,1,4,0)
;;=4^E08.349
;;^UTILITY(U,$J,358.3,58288,2)
;;=^5002517
;;^UTILITY(U,$J,358.3,58289,0)
;;=E09.311^^272^2905^31
;;^UTILITY(U,$J,358.3,58289,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58289,1,3,0)
;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,58289,1,4,0)
;;=4^E09.311
;;^UTILITY(U,$J,358.3,58289,2)
;;=^5002552
;;^UTILITY(U,$J,358.3,58290,0)
;;=E09.319^^272^2905^32
;;^UTILITY(U,$J,358.3,58290,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58290,1,3,0)
;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58290,1,4,0)
;;=4^E09.319
;;^UTILITY(U,$J,358.3,58290,2)
;;=^5002553
;;^UTILITY(U,$J,358.3,58291,0)
;;=E09.321^^272^2905^27
;;^UTILITY(U,$J,358.3,58291,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58291,1,3,0)
;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,58291,1,4,0)
;;=4^E09.321
;;^UTILITY(U,$J,358.3,58291,2)
;;=^5002554
;;^UTILITY(U,$J,358.3,58292,0)
;;=E09.329^^272^2905^28
;;^UTILITY(U,$J,358.3,58292,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58292,1,3,0)
;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58292,1,4,0)
;;=4^E09.329
;;^UTILITY(U,$J,358.3,58292,2)
;;=^5002555
;;^UTILITY(U,$J,358.3,58293,0)
;;=E09.351^^272^2905^29
;;^UTILITY(U,$J,358.3,58293,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58293,1,3,0)
;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,58293,1,4,0)
;;=4^E09.351
;;^UTILITY(U,$J,358.3,58293,2)
;;=^5002560
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GT 3950 printed Apr 09, 2024@21:58:40 Page 2
IBDEI3GT ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,58282,1,4,0)
+2 ;;=4^E08.319
+3 ;;^UTILITY(U,$J,358.3,58282,2)
+4 ;;=^5002511
+5 ;;^UTILITY(U,$J,358.3,58283,0)
+6 ;;=E08.321^^272^2905^35
+7 ;;^UTILITY(U,$J,358.3,58283,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,58283,1,3,0)
+10 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
+11 ;;^UTILITY(U,$J,358.3,58283,1,4,0)
+12 ;;=4^E08.321
+13 ;;^UTILITY(U,$J,358.3,58283,2)
+14 ;;=^5002512
+15 ;;^UTILITY(U,$J,358.3,58284,0)
+16 ;;=E08.329^^272^2905^36
+17 ;;^UTILITY(U,$J,358.3,58284,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,58284,1,3,0)
+20 ;;=3^Diab d/t Undrl Cond w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
+21 ;;^UTILITY(U,$J,358.3,58284,1,4,0)
+22 ;;=4^E08.329
+23 ;;^UTILITY(U,$J,358.3,58284,2)
+24 ;;=^5002513
+25 ;;^UTILITY(U,$J,358.3,58285,0)
+26 ;;=E08.331^^272^2905^37
+27 ;;^UTILITY(U,$J,358.3,58285,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,58285,1,3,0)
+30 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/ Macular Edema
+31 ;;^UTILITY(U,$J,358.3,58285,1,4,0)
+32 ;;=4^E08.331
+33 ;;^UTILITY(U,$J,358.3,58285,2)
+34 ;;=^5002514
+35 ;;^UTILITY(U,$J,358.3,58286,0)
+36 ;;=E08.339^^272^2905^38
+37 ;;^UTILITY(U,$J,358.3,58286,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,58286,1,3,0)
+40 ;;=3^Diab d/t Undrl Cond w/ Moderate Nonprolif Diab Retinopathy w/o Macular Edema
+41 ;;^UTILITY(U,$J,358.3,58286,1,4,0)
+42 ;;=4^E08.339
+43 ;;^UTILITY(U,$J,358.3,58286,2)
+44 ;;=^5002515
+45 ;;^UTILITY(U,$J,358.3,58287,0)
+46 ;;=E08.341^^272^2905^39
+47 ;;^UTILITY(U,$J,358.3,58287,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,58287,1,3,0)
+50 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/ Macular Edema
+51 ;;^UTILITY(U,$J,358.3,58287,1,4,0)
+52 ;;=4^E08.341
+53 ;;^UTILITY(U,$J,358.3,58287,2)
+54 ;;=^5002516
+55 ;;^UTILITY(U,$J,358.3,58288,0)
+56 ;;=E08.349^^272^2905^40
+57 ;;^UTILITY(U,$J,358.3,58288,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,58288,1,3,0)
+60 ;;=3^Diab d/t Undrl Cond w/ Severe Nonprolif Diab Retinopathy w/o Macular Edema
+61 ;;^UTILITY(U,$J,358.3,58288,1,4,0)
+62 ;;=4^E08.349
+63 ;;^UTILITY(U,$J,358.3,58288,2)
+64 ;;=^5002517
+65 ;;^UTILITY(U,$J,358.3,58289,0)
+66 ;;=E09.311^^272^2905^31
+67 ;;^UTILITY(U,$J,358.3,58289,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,58289,1,3,0)
+70 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/ Macular Edema
+71 ;;^UTILITY(U,$J,358.3,58289,1,4,0)
+72 ;;=4^E09.311
+73 ;;^UTILITY(U,$J,358.3,58289,2)
+74 ;;=^5002552
+75 ;;^UTILITY(U,$J,358.3,58290,0)
+76 ;;=E09.319^^272^2905^32
+77 ;;^UTILITY(U,$J,358.3,58290,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,58290,1,3,0)
+80 ;;=3^Diab d/t Drug/Chem w/ Unspec Diab Retinopathy w/o Macular Edema
+81 ;;^UTILITY(U,$J,358.3,58290,1,4,0)
+82 ;;=4^E09.319
+83 ;;^UTILITY(U,$J,358.3,58290,2)
+84 ;;=^5002553
+85 ;;^UTILITY(U,$J,358.3,58291,0)
+86 ;;=E09.321^^272^2905^27
+87 ;;^UTILITY(U,$J,358.3,58291,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,58291,1,3,0)
+90 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/ Macular Edema
+91 ;;^UTILITY(U,$J,358.3,58291,1,4,0)
+92 ;;=4^E09.321
+93 ;;^UTILITY(U,$J,358.3,58291,2)
+94 ;;=^5002554
+95 ;;^UTILITY(U,$J,358.3,58292,0)
+96 ;;=E09.329^^272^2905^28
+97 ;;^UTILITY(U,$J,358.3,58292,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,58292,1,3,0)
+100 ;;=3^Diab d/t Drug/Chem w/ Mild Nonprolif Diab Retinopathy w/o Macular Edema
+101 ;;^UTILITY(U,$J,358.3,58292,1,4,0)
+102 ;;=4^E09.329
+103 ;;^UTILITY(U,$J,358.3,58292,2)
+104 ;;=^5002555
+105 ;;^UTILITY(U,$J,358.3,58293,0)
+106 ;;=E09.351^^272^2905^29
+107 ;;^UTILITY(U,$J,358.3,58293,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,58293,1,3,0)
+110 ;;=3^Diab d/t Drug/Chem w/ Prolif Diab Retinopathy w/ Macular Edema
+111 ;;^UTILITY(U,$J,358.3,58293,1,4,0)
+112 ;;=4^E09.351
+113 ;;^UTILITY(U,$J,358.3,58293,2)
+114 ;;=^5002560
